» Authors » Patricia Lommel

Patricia Lommel

Explore the profile of Patricia Lommel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 725
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Saez-Llorens X, Rowley S, Wong D, Rodriguez M, Calvo A, Troitino M, et al.
Hum Vaccin Immunother . 2017 Apr; 13(6):1-16. PMID: 28368738
We previously reported 10-valent pneumococcal non-typeable Haemophilus influenzae (NTHi) protein D conjugate vaccine (PHiD-CV) efficacy in a double-blind randomized trial (ClinicalTrials.gov: NCT00466947) against various diseases, including acute otitis media (AOM)....
2.
Vesikari T, Forsten A, Seppa I, Kaijalainen T, Puumalainen T, Soininen A, et al.
J Pediatric Infect Dis Soc . 2016 Apr; 5(3):237-248. PMID: 27125273
Unlabelled: After administering the 10-valent pneumococcal polysaccharide nontypeable Haemophilus influenzae protein D-conjugated vaccine (PHiD-CV) to children aged 2-18 months, we observed a reduction in vaccine-type nasopharyngeal carriage, resulting in a...
3.
Tregnaghi M, Saez-Llorens X, Lopez P, Abate H, Smith E, Posleman A, et al.
PLoS Med . 2015 Jun; 12(6):e1001850. PMID: 26115379
No abstract available.
4.
Tregnaghi M, Saez-Llorens X, Lopez P, Abate H, Smith E, Posleman A, et al.
PLoS Med . 2014 Jun; 11(6):e1001657. PMID: 24892763
Background: The relationship between pneumococcal conjugate vaccine-induced antibody responses and protection against community-acquired pneumonia (CAP) and acute otitis media (AOM) is unclear. This study assessed the impact of the ten-valent...
5.
Palmu A, Jokinen J, Nieminen H, Rinta-Kokko H, Ruokokoski E, Puumalainen T, et al.
Lancet Infect Dis . 2013 Nov; 14(3):205-12. PMID: 24287186
Background: Antimicrobial drugs are frequently prescribed to children for respiratory tract infections such as otitis, tonsillitis, sinusitis, and pneumonia. We assessed the effect of the ten-valent pneumococcal Haemophilus influenzae protein...
6.
Palmu A, Jokinen J, Borys D, Nieminen H, Ruokokoski E, Siira L, et al.
Lancet . 2012 Nov; 381(9862):214-22. PMID: 23158882
Background: The Finnish Invasive Pneumococcal disease (FinIP) vaccine trial was designed to assess the effectiveness of a pneumococcal vaccine containing ten serotype-specific polysaccharides conjugated to Haemophilus influenzae protein D, tetanus...
7.
Prymula R, Hanovcova I, Splino M, Kriz P, Motlova J, Lebedova V, et al.
Vaccine . 2011 Jan; 29(10):1959-67. PMID: 21215830
Pneumococcal conjugate vaccines (PCV) may reduce nasopharyngeal carriage (NPC) of Streptococcus pneumoniae vaccine strains (VT), but serotype replacement with non-vaccine strains (NVT) has been reported. Bacterial NPC after PHiD-CV vaccination...
8.
Vesikari T, Karvonen A, Lindblad N, Korhonen T, Lommel P, Willems P, et al.
Pediatr Infect Dis J . 2010 May; 29(6):e47-56. PMID: 20508478
Background: A booster dose of pneumococcal conjugate vaccine may be administered at the same age as measles-mumps-rubella-varicella (MMRV) vaccination. This study examined the safety, reactogenicity, and immunogenicity of a booster...
9.
Silfverdal S, Hogh B, Bergsaker M, Skerlikova H, Lommel P, Borys D, et al.
Pediatr Infect Dis J . 2010 Feb; 28(10):e276-82. PMID: 20118683
Background: The immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) was determined following a simplified 2-dose priming and the more commonly employed 3-dose priming both followed...
10.
Prymula R, Siegrist C, Chlibek R, Zemlickova H, Vackova M, Smetana J, et al.
Lancet . 2009 Oct; 374(9698):1339-50. PMID: 19837254
Background: Although fever is part of the normal inflammatory process after immunisation, prophylactic antipyretic drugs are sometimes recommended to allay concerns of high fever and febrile convulsion. We assessed the...